A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome
1
Recently, mutations in the signal transducer and activator of transcription factor 3 gene (STAT3) have been determined to be the cause of autosomal dominant HIES. 2, 3 Most STAT3 mutations were located in the DNA-binding domain or Src homology 2 domain, whereas missense mutations were also found in the transactivation domain downstream of the Src homology 2 domain. [2] [3] [4] Here we report the first STAT3 mutation in the linker domain of the protein in a boy with HIES.
A 5-year-old Korean boy was admitted because of fever, cough, and otorrhea for a week. His parents were not consanguineous. He had no remarkable perinatal problems and had been vaccinated as scheduled. He had a history of atopic dermatitis since 6 months of age. Ingestion of eggs and milk had been restricted until 43 months of age, when he passed the open challenge test. Of note, past medical history also revealed recurrent infections, including multiple episodes of oral candidiasis. He was treated with antibiotics for an abscess on the scalp caused by group A b-hemolytic Streptococcus species at 4 months of age. He had a history of 3 hospitalizations for pneumonia without pneumatocele. Suppurative cervical lymphadenitis caused by Staphylococcus aureus, which occurred at 18 months of age, was successfully treated with incision, drainage, and antibiotics, but it recurred several times afterward. At 4 years of age, tympanostomy tubes were inserted in the eardrums bilaterally for recurrent otitis media caused by Streptococcus pneumoniae. Family history revealed no members with relevant allergic or immunologic diseases.
On physical examination, his height was 104.6 cm (10th percentile), and his weight was 17 kg (25th percentile). He had coarse facial features with a low hairline and hypertelorism and genu valgum. A whitish plaque was found on the soft palate. The left external auditory canal was wet, and the tympanostomy tube was not in situ in his left ear. A 1.0 3 1.0 cm, hard, tender lymph node was palpable in the left supraclavicular area. Fine crackles were heard on both lung fields, and his skin was slightly dry. Complete blood cell counts demonstrated a normal total eosinophil count (<400 cells/mL), although his eosinophil count had been up to 7000 cells/mL at 6 months of age. Plain chest radiographic analysis demonstrated bilateral peribronchial infiltrates, and Haemophilus influenzae was isolated from sputum culture. The serum IgE level was increased at 3980 IU/mL. Results of other immunologic studies, such as serum immunoglobulin level measurement and the nitroblue tetrazolium test, were normal. Lymphocyte subset analyses revealed normal levels of both CD4
1 and CD8 1 T cells (1950/mL and 1500/mL, respectively). His National Institutes of Health score was 45 points (''probably affected''; Table I ). 5 Written informed consent was obtained from the parents for molecular genetic studies for STAT3 mutations. Direct sequencing analysis of the STAT3 gene was performed with genomic DNA isolated from peripheral blood leukocytes. The Wizard Genomic DNA Purification Kit was used according to the manufacturer's instructions (Promega, Madison, Wis). As a result, we identified an amino acid-changing variation in the linker domain of the STAT3 gene; it was an A-to-G transition at the nucleotide 1591 position (c.1591A>G) leading to substitution of lysine at the amino acid position 531 to glutamic acid (p.K531E). K531E was not found in the single nucleotide polymorphism database (dbSNP; www.ncbi.nlm.nih.gov/projects/ SNP/) nor has it been reported as a mutation in patients with HIES. Family study revealed that neither of the patient's parents had the mutation, and his 3-year-old younger sister is also homozygous for the wild-type allele. Comparative genomics analyses performed by aligning nucleotide sequences of different species showed that the K531 residue in the linker domain is perfectly conserved (Fig 1, A) . Functional prediction of the variation with the PolyPhen (Polymorphism Phenotyping) program (http:// genetics.bwh.harvard.edu/pph/) and the Sorting Intolerant From Tolerant program (http://blocks.fhcrc.org/sift/SIFT.html) predicted ''probably damaging (PSIC score difference, 2.064)'' and ''deleterious (SIFT score 0)'' values, respectively. We also observed that the K531E variation did not occur in 200 control chromosomes from 100 healthy individuals (frequency, 0%). Lastly, we performed flow cytometric analyses to demonstrate the functional deficit of the STAT3 protein, as recently described. 4 As a result, we observed that the patient had impaired generation of IL-17-secreting CD4 1 T cells (T H 17 cells) on stimulation compared with control levels (Fig 1, B) . Collectively, all these findings indicate that this de novo heterozygous missense mutation, K531E, in the linker domain of STAT3 was the diseasecausing mutation in the patient. It was reported that STAT3 mutations were not always found in patients with HIES. 3, 4 In addition, homozygous mutations in the tyrosine kinase 2 gene are the genetic defect in a subgroup of patients with HIES. 6 The K531E mutation described in this report is the first mutation in the linker domain of STAT3, further expanding the genetic heterogeneity of HIES. According to recent studies, 4, 7, 8 patients with HIES with STAT3 mutations showed absent or markedly decreased levels of T H 17 cells in their peripheral blood. By comparison, patients with HIES or HIES-like symptoms (without recurrent candidiasis/staphylococcal abscess or lung infection) without STAT3 mutations were shown to have higher levels of T H 17 cells than those with mutations, albeit still significantly lower than levels seen in control individuals. The functional prediction by means of bioinformatics analyses and population screening supported that K531E is a mutation affecting a highly conserved amino acid residue with a potential to adversely affect the linker domain. Indeed, we could demonstrate that the T H 17 response was markedly decreased in the patient compared with that seen in healthy control subjects. The level of decrease was comparable with that seen in previously reported patients with STAT3 mutations in other domains.
In summary, we identified the first mutation in the linker domain of STAT3 in a patient with HIES. Further cases are needed to elucidate any genotype-phenotype correlations in mutations occurring in the linker domain in comparison with those in other STAT3 domains.
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